Skip to main content

Table 3 Effect of pantoprazole and lycopene on biochemical markers of oxidative stress in experimental animals

From: Effect of lycopene against gastroesophageal reflux disease in experimental animals

Group

Treatment

Glutathione (mg %)

Superoxide dismutase (unit of SOD/ mg of protein)

Catalase (nM of H 2 O 2 /min /mg of protein)

Thiobarbituric acid reactive substances (nM of MDA/mg of protein)

Protein carbonyl (nM/ml)

Group-I

Sham control (Normal saline,3 ml/kg, p.o)

4.71 ± 0.42***

110.39 ± 66.13

4.45 ± 0.40***

1.20 ± 0.06***

48.18 ± 1.82***

Group-II

Esophagitis control (Normal saline,3 ml/kg, p.o)

3.69 ± 0.10

64.21 ± 31.76

2.58 ± 0.71

5.17 ± 0.01

162.12 ± 1.74

Group-III

Lycopene (50 mg/kg, p.o)

4.78 ± 0.10***

71.70 ± 17.90

4.05 ± 0.78**

3.28 ± 0.07***

129.39 ± 5.04***

Group-IV

Lycopene (100 mg/kg,p.o)

4.02 ± 0.20c

64.68 ± 15.09

4.10 ± 0.37***

3.03 ± 0.03***c

112.50 ± 3.00***c

Group-V

Pantoprazole (30 mg/kg, p.o)

4.26 ± 0.05**

67.89 ± 27.06

3.44 ± 0.38

2.84 ± 0.04***

98.26 ± 3.07***

  1. Each group contains six animals. Values are represented as mean ± SD.
  2. Statistical significance compared to toxic control using one-way ANOVA followed by Bonferroni test (**P < 0.01, and ***P < 0.001).
  3. Statistical significance compared between lycopene (50 mg/kg) and lycopene (100 mg/kg) using one-way ANOVA followed by Bonferroni test (c P < 0.001).